Testezone 250 - Alphazone Pharmaceuticals

Schering AG developed the European version of testosterone enanthate under the trade name Testoviron Depot. Released in the 1950s, it featured a depot effect that supported longer therapeutic coverage than previous esters. Testoviron became widely used in hormone therapy across Germany and other countries. After Bayer’s acquisition of Schering, the product remained in active production. Its reliability and long clinical history made it one of the most recognized testosterone injectables in global medical practice for over fifty years.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Testezone 250 by Alphazone Pharmaceuticals, consult with your doctor or healthcare professional.